Data,study_id,Channel,year,id,Owner,group_id,group_desc,SKU,country,continent,region,city,country,city,lat2,long2,link,time_MAX,Sales Value Monthly Change,MissingTime50,time_MIN,detailed_time,exp_dur,fu_dur,age_base,age_category,age_SD,days_ps,days_cat,yrs_ps,stroke_type,nihss_base,mmse_base,mMmse_base,fim_base,brunstrom_base,frenchay_base,fac_base,barthel_base,mBarthel_base,motricity_base,BBS_base,BBT_base,gcs_base,MAS_base,sis_base,rivermead_base,ashworth_base,mAshworth_base,rankin_base,bdi_base,cesd_base,ops_base,terminal_dropout,outcome_name,outcome_extremity,ue_subscale,le_subscale,outcomenamecat,SCOAR_outcome,p_outcome_stated,itt_analysis,base_n,base_m,base_sd,difference_score,term_n,term_m,term_sd,diff_base,diff_term,fu_n,fu_m,fu_sd,est_corr,term_diff,term_s_diff,fu_diff,fu_s_diff,term_d,fu_d,j_corr_factor,Price,MissingTermG,MissingData,fu_g,term_Vd,fu_Vd,term_Vg,termvginv,fu_Vg,chck2,notes
1/12/2012,92,laver,2012,laver (2012),exp,202,balance training using Wii fit,http://www.ncbi.nlm.nih.gov/pubmed/22409245,Australia,Australia,adelaide,adelaide,Australia,adelaide,-34.9285,138.6007,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/22409245"" target=""_blank"">laver (2012)</a>",4.2,4.2,Time 50 OK,4.2,1,12.3,,85.2,Remaining,,2,<90days,0.005479452,0,,26.23,,,,,,,,,,,,,,,,,,,,,2,tug,le,,balance,balance,lohse,1,1,22,37.95,18.77,,22,27.9,10.44,,,,,,0.5,-10.05,15.18727263,,18.77,0.661738302,,0.963855422,0.63782005,Term G OK,All OK,,0.055406763,,0.05147384,19.42734406,,,sign reversed for time measure
1/12/2012,84,kuys,2011,kuys (2011),ctrl,184,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/20921032,Australia,Australia,brisbane,brisbane,Australia,brisbane,-27.4698,153.0251,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/20921032"" target=""_blank"">kuys (2011)</a>",30,30,Time 50 OK,30,2,42,126,72,Remaining,17,49,<90days,0.134246575,0,,28,,,,,,,80,,,,,"<4,5,6",,,,,,,,,0,10mwt,le,,speed,speed,lohse,0,1,15,0.58,0.36,,15,0.68,0.37,0,0,12,0.66,0.41,0.5,0.1,0.365034245,0.08,0.382805434,0.273946901,0.208983449,0.945454545,0.259004342,Term G OK,All OK,0.197584352,0.06916823,0.068122469,0.061828395,16.17379846,0.060893606,Yes,"The authors report and intention to treat analysis, but according to their tables, it does not look like missing data were carried forward."
1/12/2012,11,brock,2011,brock (2011),exp,23,bobath + task specific practice,http://www.ncbi.nlm.nih.gov/pubmed/21788266,Australia,Australia,victoria,melbourne,Australia,melbourne,-37.8136,144.9631,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/15574110"" target=""_blank"">blennerhassett (2004)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/21788266"" target=""_blank"">brock (2011)</a>",6,6,Time 50 OK,6,1,14,,61.3,50th Percentile,13,60.3,<90days,0.165205479,1,,,,,,,,,,,,,,,,,,,,,,,2,6minwt,le,,capacity,capacity,lohse,1,0,14,102.6,64.5,,12,192.5,113.5,0,0,,,,0.5,89.9,90.32072483,,64.5,0.995341879,,0.941176471,0.936792357,Term G OK,All OK,,0.106810909,,0.094614508,10.56920362,,Yes,
1/12/2012,3,ada,2013,ada (2013),exp,6,four months of walking training,http://www.ncbi.nlm.nih.gov/pubmed/23464674,Australia,Australia,new south wales,sydney,Australia,sydney,-33.8688,151.2093,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/10768528"" target=""_blank"">dean (2000)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/14586916"" target=""_blank"">ada (2003)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/15482247"" target=""_blank"">mcclellan (2004)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/18422947"" target=""_blank"">lee (2008)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/23464674"" target=""_blank"">ada (2013)</a>",24,24,Time 50 OK,24,1,120,365,70,Remaining,,660,>1year,1.808219178,0,,,,,,,,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,1,1,34,232,124,,34,289,131,,,34,250,130,0.5,57,127.5480302,18,127.0354281,0.446890477,0.141692757,0.977099237,0.436656344,Term G OK,All OK,0.138447884,0.032348693,0.029707012,0.030884038,32.37918565,0.028361965,,
1/12/2012,43,feys,1998,feys (1998),exp,94,SC + sensory therapy,http://www.ncbi.nlm.nih.gov/pubmed/9550512,Belgium,Europe,leuven,leuven,Belgium,leuven,50.8798,4.7005,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/9550512"" target=""_blank"">feys (1998)</a>",30,30,Time 50 OK,30,2,42,365,65.62,75th Percentile,,21.4,<90days,0.058630137,1,,,,,,,,,,,,,,,,,,,,,,,10,fma-ue,ue,fma,,fma,lohse,0,0,50,2.367857143,0.782868222,,40,2.932142857,0.707106781,,,37,3.45,0.63134534,0.5,0.564285714,0.750236705,1.082142857,0.72258311,0.752143571,1.49760331,0.984615385,0.740572131,Term G OK,All OK,1.474563259,0.0256572,0.042428157,0.02487382,40.20291214,0.041132717,Yes,primary outcome was the log of the Brunnstrom Fugl Meyer; estimated from Figure 1
1/12/2012,145,ribeiro,2013,ribeiro (2013),exp,330,"PNF therapy, no other gait therapies given",http://www.ncbi.nlm.nih.gov/pubmed/23172402,Brasil,South America,natal,natal,Brasil,natal,-5.7793,-35.2009,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/23172402"" target=""_blank"">ribeiro (2013)</a>",6,6,Time 50 OK,6,1,28,,58.33,50th Percentile,8.94,593.1,>1year,1.624931507,1,6.44,,,68,,,3.22,,,,,,,,,,,1.33,,,,,2,STREAM,,,,other,lohse,0,0,9,66.2,17.8,,9,74.6,18.2,,,9,,,0.5,8.4,18.00111108,,17.8,0.466637863,,0.903225806,0.42147936,Term G OK,All OK,,0.123208383,,0.100515476,9.948716753,,,
1/12/2012,46,fuzaro,2011,fuzaro (2011),exp,100,modified forced use therapy,http://www.ncbi.nlm.nih.gov/pubmed/22378476,Brasil,South America,sao paulo,sao paulo,Brasil,sao paulo,-23.5505,-46.6333,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/22378476"" target=""_blank"">fuzaro (2011)</a>",23,11.5,Time 50 OK,0,1,28,90,57.8,50th Percentile,15.65,924.9,>1year,2.533972603,1,,,,,,,,,,,45,,,,48.61,,,,,,,,12,SIS,,,,other,lohse,0,0,18,48.61,7.31,,18,54.44,8.41,,,18,53.78,9.42,0.5,5.83,7.879219504,5.17,8.431266216,0.739921003,0.61319378,0.955223881,0.706790212,Term G OK,All OK,0.585737342,0.070763419,0.066000184,0.06456827,15.48748325,0.060222043,Yes,
1/12/2012,119,olney,2006,olney (2006),exp,266,one week supervised followed by 9 weeks home training,http://www.ncbi.nlm.nih.gov/pubmed/16410482,Canada,North America,ontario,kingston,Canada,kingston,44.2312,-76.486,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/10960936"" target=""_blank"">walker (2000)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/16410482"" target=""_blank"">olney (2006)</a>",45,45,Time 50 OK,45,1,70,365,65.8,75th Percentile,,1241,>1year,3.4,0,,,,,,,,,,,,,,,,,,,,,,,3,6minwt,le,,capacity,capacity,lohse,1,1,35,0.76,0.34,,32,0.87,0.37,,,25,0.91,0.36,0.5,0.11,0.354624395,0.15,0.348415131,0.310187346,0.430520912,0.977777778,0.303294294,Term G OK,All OK,0.420953781,0.029945946,0.031219261,0.028629803,34.92863713,0.029847155,,"the authors state intention to treat, but also state that no missing values were imputed and observations were not carried forward."
1/12/2012,185,vistin,1998,vistin (1998),ctrl,420,treadmill walking with full weight bearing,http://www.ncbi.nlm.nih.gov/pubmed/9626282,Canada,North America,quebec,montreal,Canada,montreal,45.5017,-73.5673,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/15293485"" target=""_blank"">salbach (2004)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/9626282"" target=""_blank"">vistin (1998)</a>",7.92,7.92,Time 50 OK,7.92,1,42,90,66.7,75th Percentile,,78.4,<90days,0.214794521,0,,,,,,,,,,,21.9,,,,,,,,,,,,14,bbs,le,,balance,balance,lohse,0,0,50,21.9,16.6,,36,27.76,21.3,,,36,34.35,21.3,0.5,5.86,18.70242854,12.45,18.70242854,0.313328292,0.665688949,0.984615385,0.308507857,Term G OK,All OK,0.655447581,0.020981746,0.024431418,0.02034112,49.16150143,0.023685464,,
1/12/2012,147,richards,2004,richards (2004),exp,334,treadmill training and isokinetic exercise,http://www.ncbi.nlm.nih.gov/pubmed/15537991,Canada,North America,quebec,quebec city,Canada,quebec city,46.8139,-71.208,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/15537991"" target=""_blank"">richards (2004)</a>",39.1,39.1,Time 50 OK,39.1,2,56,,62.9,75th Percentile,12,52,<90days,0.142465753,1,,,,,,,,,,,,,,,,,,,,,,,2,gait speed SSV,le,,speed,speed,lohse,1,1,32,26.51,14.22,,32,52.77,33.25,,,32,62.17,34.94,0.5,26.26,25.57118398,35.66,26.67406981,1.026937197,1.336878859,0.975609756,1.001889948,Term G OK,All OK,1.304272057,0.047728125,0.059175704,0.045428317,22.0127019,0.056324287,,
1/12/2012,31,desrosiers,2005,desrosiers (2005),ctrl,67,CPT dosage matched to experimental group,http://www.ncbi.nlm.nih.gov/pubmed/16180593,Canada,North America,quebec,sherbrooke,Canada,sherbrooke,45.401,-71.8824,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/16180593"" target=""_blank"">desrosiers (2005)</a>",15,15,Time 50 OK,15,1,35,,74.3,Remaining,,35.4,<90days,0.096986301,1,,,86.1,117.3,,,,,,,,,,,,,,,,11.6,,,5,fma-ue,ue,fma,,fma,lohse,0,0,21,47,16.1,,16,51.3,14.1,0,,,,,0.5,4.3,15.27495616,,16.1,0.281506536,,0.962025316,0.270816415,Term G OK,All OK,,0.049505855,,0.045817308,21.82581307,,Yes,
1/12/2012,55,harris,2009,harris (2009),exp,118,supplementary arm and hand therapy plus usual care,http://www.ncbi.nlm.nih.gov/pubmed/19359633,Canada,North America,vancouver,vancouver,Canada,vancouver,49.2827,-123.1207,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/16181164"" target=""_blank"">pang (2005)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/16401430"" target=""_blank"">pang (2006)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/19359633"" target=""_blank"">harris (2009)</a>",43.2,43.2,Time 50 OK,43.2,2,28,118,69.4,Remaining,15.3,20.5,<90days,0.056164384,1,,26.7,,,,,,,,,,,,,,,,,,,,,0,Chedoke Arm Hand,,,,other,lohse,1,1,53,32.6,15.3,,53,46.7,14.7,,,53,45.4,14.7,0.5,14.1,15.0029997,12.8,15.0029997,0.939812056,0.853162718,0.985507246,0.926191592,Term G OK,All OK,0.840798041,0.027200441,0.025734779,0.026417735,37.85335874,0.024994249,,SD was estimated from CI at follow up
1/12/2012,42,fang,2003,fang (2003),exp,91,additional early physiotherapy,http://www.ncbi.nlm.nih.gov/pubmed/12971705,China,Asia,guangzhou,guangzhou,China,guangzhou,23.1291,113.2644,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/12971705"" target=""_blank"">fang (2003)</a>",15,15,Time 50 OK,15,1,30,180,65.49,75th Percentile,10.94,7,<90days,0.019178082,1,,19.37,,,,,,25.7,,,,,14.04,,,,,,,,,,28,fma-ue,ue,fma,,fma,lohse,0,0,50,16.5,16.34,,50,25.89,20.83,1,0,14,41.86,23.82,0.5,9.39,18.72010283,25.36,18.16540739,0.501599809,1.396060074,0.984615385,0.493882889,Term G OK,All OK,1.374582227,0.022516024,0.039489837,0.021828552,45.8115591,0.038284112,Yes,
1/12/2012,90,lau,2011,lau (2011),ctrl,197,gait training on the treadmill at steady speed,http://www.ncbi.nlm.nih.gov/pubmed/21698340,China,Asia,hong kong,hong kong,China,hong kong,22.3964,114.1095,"<a href=""http://stroke.ahajournals.org/content/39/1/154.short"" target=""_blank"">ng (2008)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/17901383"" target=""_blank"">ng (2007)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/19074684"" target=""_blank"">chan (2009)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/19509438"" target=""_blank"">hui chan (2009)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/21698340"" target=""_blank"">lau (2011)</a>",20,20,Time 50 OK,20,1,14,,72.1,Remaining,,12.7,<90days,0.034794521,0,,>23,,,,,,,,,,,,,,,,0 or 1,,,,,2,10mwt SSV,le,,speed,speed,lohse,0,0,15,0.3,0.19,,13,0.52,0.21,,,,,,0.5,0.22,0.199480093,,0.19,1.102866939,,0.945454545,1.04271056,Term G OK,All OK,,0.107210516,,0.095833797,10.43473212,,,
1/12/2012,71,jin,2013,jin (2013),exp,156,progressive cycling intervention,http://www.ncbi.nlm.nih.gov/pubmed/23535796,China,Asia,nanjing,nanjing,China,nanjing,32.0603,118.7969,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/23535796"" target=""_blank"">jin (2013)</a>",40.2,40.2,Time 50 OK,40.2,1,84,,57.6,50th Percentile,,561,>1year,1.536986301,1,,,,,,,,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,1,0,65,0.59,0.178,,65,0.609,0.179,,,,,,0.5,0.019,0.1785007,,0.178,0.106442159,,0.988235294,0.105189899,Term G OK,All OK,,0.015471769,,0.015109869,66.18191064,,,
1/12/2012,54,han,2013,han (2013),exp,116,CPT at increased intensity,http://www.ncbi.nlm.nih.gov/pubmed/22801472,China,Asia,shandong,shandong,China,shandong,36.6685,117.0204,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/22801472"" target=""_blank"">han (2013)</a>",60,60,Time 50 OK,60,1,42,84,53.7,25th Percentile,,42.9,<90days,0.117534247,1,,,,,,,,62.5,,,,,,,,,,<3,,,,,0,fma-ue,ue,fma,,fma,lohse,0,0,10,8.2,3.43,,10,12.3,6.55,,,10,19.7,7.09,0.5,4.1,5.228164114,11.5,5.569245909,0.784214097,2.064911514,0.914285714,0.716995746,Term G OK,All OK,1.887919098,0.130749588,0.313192978,0.109295982,9.149467178,0.261803763,,
1/12/2012,70,jin,2012,jin (2012),exp,154,progressive cycling training with lower limb weights,http://www.ncbi.nlm.nih.gov/pubmed/22376194,China,Asia,taixing,taixing,China,taixing,32.1719,120.0517,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/22376194"" target=""_blank"">jin (2012)</a>",46.8,46.8,Time 50 OK,46.8,1,56,,57,25th Percentile,,555,>1year,1.520547945,1,,,,,,,,,,,47.9,,,,,10.3,,,,,,,0,6minwt,le,,capacity,capacity,lohse,1,0,68,0.588,0.18,,68,0.607,0.18,,,,,,0.5,0.019,0.18,,0.18,0.105555556,,0.988764045,0.104369538,Term G OK,All OK,,0.014787809,,0.014457365,69.16889765,,,
1/12/2012,134,peurala,2005,peurala (2005),exp,303,BWS gait training with stimulation + CPT,http://www.ncbi.nlm.nih.gov/pubmed/16084808,Finland,Europe,kuopio,kuopio,Finland,kuopio,62.898,27.6782,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/16084808"" target=""_blank"">peurala (2005)</a>",20.4,20.4,Time 50 OK,20.4,3,21,,53.3,25th Percentile,8.9,949,>1year,2.6,1,,,,,,,4.1,,,,,,,,,,,,,,,,0,10mwt MAX,le,,speed,speed,lohse,0,0,15,44,36.2,,15,35.9,29.9,,,15,,,0.5,-8.1,33.1997741,,36.2,0.243977564,,0.945454545,0.230669697,Term G OK,All OK,,0.068650835,,0.061365903,16.29569437,,,sign reversed for time measure
1/12/2012,182,varoqui,2011,varoqui (2011),ctrl,413,standing practice (group c),http://www.ncbi.nlm.nih.gov/pubmed/21628724,France,Europe,montpellier,montpellier,France,montpellier,43.6108,3.8767,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/21628724"" target=""_blank"">varoqui (2011)</a>",3,3,Time 50 OK,3,1,28,,60.12,50th Percentile,,72.14,<90days,0.197643836,1,,,,51.29,,,3,,,,,,,,,,,2.71,,,,,0,pass,,,,other,lohse,0,0,7,27.57,4.65,,7,31.14,4.45,,,,,,0.5,3.57,4.551098768,,4.65,0.784425955,,0.869565217,0.682109527,Term G OK,All OK,,0.186808863,,0.141254339,7.079428548,,,
1/12/2012,66,huseman,2007,huseman (2007),exp,147,lokomat gait training,http://www.ncbi.nlm.nih.gov/pubmed/17204680,Germany,Europe,bad aibling,bad aibling,Germany,bad aibling,47.864,12.0093,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/17204680"" target=""_blank"">huseman (2007)</a>",20,20,Time 50 OK,20,1,28,,60,50th Percentile,,79,<90days,0.216438356,1,,,,,,,,,,,,,,,,,,,,,,,2,10mwt,le,,speed,speed,lohse,1,1,16,0.14,0.08,,16,0.2,0.12,,,,,,0.5,0.06,0.10198039,,0.08,0.588348405,,0.949152542,0.558432385,Term G OK,All OK,,0.073317308,,0.06605087,15.139846,,,
1/12/2012,58,hesse,2011,hesse (2011),exp,125,intermittent high intensity,http://www.ncbi.nlm.nih.gov/pubmed/7762049,Germany,Europe,berlin,berlin,Germany,berlin,52.52,13.405,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/12468788"" target=""_blank"">werner (2002)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/14606736"" target=""_blank"">schauer (2003)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/15473116"" target=""_blank"">eich (2004)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/17213237"" target=""_blank"">pohl (2007)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/7762049"" target=""_blank"">hesse (2011)</a>",120,120,Time 50 OK,120,1,365,455,62.4,75th Percentile,11.3,114.8,<1year,0.314520548,1,,,,,,,,,,,,8.1,,,,9.4,,6.7,,,,,0,rivermead mobility,,,,other,lohse,1,1,25,9.4,2.8,,25,12.2,2.1,,,25,12.2,1.7,0.5,2.8,2.474873734,2.8,2.316246964,1.13137085,1.208852097,0.968421053,1.095643349,Term G OK,All OK,1.17067782,0.0656,0.069226468,0.06152226,16.25427935,0.064923305,Yes,
1/12/2012,140,pohl,2002,pohl (2002),ctrl,316,conventional gait training,http://www.ncbi.nlm.nih.gov/pubmed/11823669,Germany,Europe,kreischa,kreischa,Germany,kreischa,50.9443,13.7589,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/11823669"" target=""_blank"">pohl (2002)</a>",15,15,Time 50 OK,15,1,28,,61.6,50th Percentile,,112.7,<1year,0.308767123,1,,<26,,,,,>3,,,,,,,,,,0.1,,,,,,0,10mwt SSV,le,,speed,speed,lohse,0,0,20,0.66,0.42,,20,0.97,0.64,,,20,,,0.5,0.31,0.541294744,,0.42,0.572700924,,0.96,0.549792887,Term G OK,All OK,,0.058199659,,0.053636805,18.64391438,,,
1/12/2012,100,luft,2008,luft (2008),ctrl,221,stretching,http://www.ncbi.nlm.nih.gov/pubmed/18757284,Germany,Europe,tubingen,tubingen,Germany,tubingen,48.5216,9.0576,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/18757284"" target=""_blank"">luft (2008)</a>",0,0,Time 50 OK,0,1,168,,63.6,75th Percentile,10,1338,>1year,3.665753425,1,3.6,>18,,,,,,,,,,,,,,,,,,,>16,,20,10mwt SSV,le,,speed,speed,lohse,1,0,34,0.53,0.28,,34,0.57,,,,,,,0.5,0.04,0.28,,0.28,0.142857143,,0.977099237,0.139585605,Term G OK,All OK,,0.029711885,,0.028366617,35.25270567,,Yes,"too many inferences had to be made (CI from figure, df for CI, etc) to get an accurate effect size"
1/12/2012,5,arya,2012,arya (2012),exp,11,"""meaningful"" task specific therapy",http://www.ncbi.nlm.nih.gov/pubmed/22668675,India,Asia,uttar pradesh,lucknow,India,lucknow,26.8467,80.9462,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/22120031"" target=""_blank"">verma (2011)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/22668675"" target=""_blank"">arya (2012)</a>",20,20,Time 50 OK,20,1,28,56,51.67,25th Percentile,,83.44,<90days,0.22860274,1,5.63,,,,,,,,,,,,,,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,0,1,51,11.98,9.74,,51,29,14.7,0,0,51,32.02,15.47,0.5,17.02,12.46911384,20.04,12.92649411,1.364972701,1.550304346,0.984924623,1.344395223,Term G OK,All OK,1.526932924,0.037874024,0.043171015,0.036740701,27.21777138,0.041879188,Yes,
1/12/2012,125,pandian,2012,pandian (2012),exp,280,motor relearning programme,http://www.ncbi.nlm.nih.gov/pubmed/22703742,India,Asia,new delhi,new delhi,India,new delhi,28.6139,77.209,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/22703742"" target=""_blank"">pandian (2012)</a>",12,12,Time 50 OK,12,1,28,,51.67,25th Percentile,,1088,>1year,2.980821918,1,,,,,,,,,,,,,,,,,,,,,,,0,fma-wh,ue,fma,,fma,lohse,0,0,15,12.33,3.26,,15,14.13,3.18,,,,,,0.5,1.8,3.220248438,,3.26,0.558963085,,0.945454545,0.528474189,Term G OK,All OK,,0.077081324,,0.068901785,14.5134121,,,
1/12/2012,157,schwartz,2009,schwartz (2009),exp,356,robot assisted gait training,http://www.ncbi.nlm.nih.gov/pubmed/19627940,Israel,Asia,jerusalem,jerusalem,Israel,jerusalem,31.7683,35.2137,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/19627940"" target=""_blank"">schwartz (2009)</a>",20,20,Time 50 OK,20,2,42,,65,75th Percentile,8.5,23.6,<90days,0.064657534,1,10.4,,,,,,,,,,,,,,,,,,,,,,8,FIM motor,,,,other,lohse,0,1,37,44.1,13.1,,37,66.9,15.6,,,,,,0.5,22.8,14.40433962,,13.1,1.582856319,,0.979020979,1.549649543,Term G OK,All OK,,0.060884245,,0.058356458,17.13606402,,,
1/12/2012,176,treger,2012,treger (2012),exp,401,mcimt,http://www.ncbi.nlm.nih.gov/pubmed/22750958,Israel,Asia,tel aviv,tel aviv,Israel,tel aviv,32.0853,34.7818,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/18988916"" target=""_blank"">mirelman (2009)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/22750958"" target=""_blank"">treger (2012)</a>",57.5,37.5,Time 50 OK,17.5,1,14,,62,50th Percentile,,39.8,<90days,0.109041096,1,3.5,,,17.4,,,,,,,,,,,,,,,,,,,0,mft,,,,other,lohse,0,0,9,10.2,21.6,1,9,15.6,,,,,,,0.5,5.4,21.6,,21.6,0.25,,0.903225806,0.225806452,Term G OK,All OK,,0.114583333,,0.093479015,10.69758812,,Yes,
1/12/2012,10,bolognini,2011,bolognini (2011),ctrl,20,sham tDCS + CIMT,http://www.ncbi.nlm.nih.gov/pubmed/21803933,Italy,Europe,milan,milan,Italy,milan,45.4654,9.1859,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/20053951"" target=""_blank"">jonsdottir (2010)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/21803933"" target=""_blank"">bolognini (2011)</a>",184,112,Time 50 OK,40,1,14,42,50.8,25th Percentile,,780,>1year,2.136986301,1,,29.57,,,,,,15.14,,,,,,,,,,,,12,,,0,jebsen taylor hand function,ue,,,other,lohse,1,0,7,95.68,105.8,,7,81.83,105.8,,,7,86.79,99.59,0.5,-13.85,105.8,-8.89,102.7419294,0.130907372,0.086527478,0.869565217,0.113832498,Term G OK,All OK,0.075241285,0.144081196,0.143391929,0.108946084,9.178852174,0.108424899,,reverse the sign for a time based DV; means and SDs estimated from figure 2
1/12/2012,32,di lauro,2003,di lauro (2003),exp,69,CPT + CPT,http://www.ncbi.nlm.nih.gov/pubmed/14586603,Italy,Europe,naples,naples,Italy,naples,40.8518,14.2681,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/14586603"" target=""_blank"">di lauro (2003)</a>",28,28,Time 50 OK,28,1,14,180,69.3,Remaining,,1,<90days,0.002739726,1,10.8,,,,,,,1.5,,,,,,,,,,,,,,,4,bartel,,,,other,lohse,0,0,31,1.4,1.4,,27,3.2,2,0,0,24,8,2.8,0.5,1.8,1.705034562,6.6,2.124075826,1.055697075,3.107233706,0.974789916,1.029082863,Term G OK,All OK,3.028900083,0.050233812,0.187982279,0.04773294,20.9498933,0.178623653,Yes,
1/12/2012,110,morone,2011,morone (2011),exp,244,robot assisted therapy for the high motricity group,http://www.ncbi.nlm.nih.gov/pubmed/21444654,Italy,Europe,rome,rome,Italy,rome,41.9028,12.4964,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/21444654"" target=""_blank"">morone (2011)</a>",60,60,Time 50 OK,60,1,28,96.33,68.33,Remaining,13.35,21.92,<90days,0.060054795,1,,>24,,,,,0,,,52,,,,,,,,1.75,,,,,4,fac,le,,,other,lohse,1,1,12,0,0.43,,12,2.2,0.8,,,12,3.59,1.1,0.5,2.2,0.642222703,3.59,0.83513472,3.425602973,4.29870764,0.930232558,3.186607417,Term G OK,All OK,3.998797805,0.572281489,0.853286974,0.495213836,2.019329686,0.738377046,,
1/12/2012,83,kiper,2011,kiper (2011),exp,183,CPT + reinforcing feedback in a VE,http://www.ncbi.nlm.nih.gov/pubmed/22127938,Italy,Europe,venice,venice,venice,venice,45.4408,12.3155,"<a href=""http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=4362151&tag=1"" target=""_blank"">piron (2007)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/19841835"" target=""_blank"">piron (2009)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/20581337"" target=""_blank"">piron (2010)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/22127938"" target=""_blank"">kiper (2011)</a>",40,40,Time 50 OK,40,1,28,,64,75th Percentile,,171,<1year,0.468493151,0,,>24,,,,,,,,,,,,,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,0,0,40,39.1,17,,40,48.9,15.2,,,,,,0.5,9.8,16.12513566,,17,0.607746825,,0.980645161,0.595983983,Term G OK,All OK,,0.029616953,,0.028481585,35.11040555,,,
1/12/2012,161,smania,2012,smania (2012),ctrl,364,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/22661278,Italy,Europe,verona,verona,Italy,verona,45.4408,12.3155,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/22661278"" target=""_blank"">smania (2012)</a>",20,20,Time 50 OK,20,1,14,90,68.25,Remaining,,281.4,<1year,0.770958904,1,,>23,,,,,,,,"<11,>26",,,,,,,0.74,,,,,,3,wmft,ue,wmft,,wmft,lohse,0,1,29,2.4,0.81,,29,2.92,0.86,,,29,3.01,0.75,0.5,0.52,0.835374168,0.61,0.78057671,0.622475557,0.781473483,0.972972973,0.605651893,Term G OK,All OK,0.760352578,0.041163376,0.045012083,0.038968397,25.66182027,0.042611877,Yes,
1/12/2012,171,tanaka,2012,tanaka (2012),exp,391,GaitMaster 4,http://www.ncbi.nlm.nih.gov/pubmed/22275464,Japan,Asia,tsukuba,tsukuba,Japan,tsukuba,36.0835,140.0766,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/22275464"" target=""_blank"">tanaka (2012)</a>",4,4,Time 50 OK,4,1,28,56,63,75th Percentile,10,1662,>1year,4.553424658,1,,>23,,79.9,,,,,,,,,,,,,,,,,,,0,gait speed,le,,speed,speed,lohse,0,0,7,0.75,0.42,,7,0.85,0.45,,,,,,0.5,0.1,0.435258544,,0.42,0.229748506,,0.869565217,0.199781309,Term G OK,All OK,,0.146627455,,0.110871422,9.01945679,,Yes,
1/12/2012,178,van deldan,2013,van deldan (2013),exp,406,bilateral arm training with auditory cuing,http://www.ncbi.nlm.nih.gov/pubmed/23868279,Netherlands,Europe,amsterdam,amsterdam,Netherlands,amsterdam,52.3702,4.8952,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/10421300"" target=""_blank"">kwakkel (1999)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/10548673"" target=""_blank"">van der lee (1999)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/18295624"" target=""_blank"">janssen (2008)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/23868279"" target=""_blank"">van deldan (2013)</a>",18,18,Time 50 OK,18,1,42,84,62.6,75th Percentile,,54.6,<90days,0.149589041,0,,>23,,,,,,,,63.9,,,,,collected,,,,,,,,1,arat,ue,arat,,arat,lohse,1,0,19,25.8,16.1,1,18,39.9,,0,1,17,44.4,,0.5,14.1,16.1,18.6,16.1,0.875776398,1.155279503,0.957746479,0.838771761,Term G OK,All OK,1.106464876,0.072815376,0.087754493,0.066791966,14.97186054,0.080495294,,Change scores estimated from Figure 2
1/12/2012,180,van nes,2006,van nes (2006),exp,409,exercise therapy with music + CPT,http://www.ncbi.nlm.nih.gov/pubmed/16902175,Netherlands,Europe,nijmegen,nijmegen,Netherlands,nijmegen,51.8126,5.8372,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/16902175"" target=""_blank"">van nes (2006)</a>",186.6,186.6,Time 50 OK,186.6,1,42,84,62.6,75th Percentile,,34,<90days,0.093150685,1,,,,,,,1,9.9,,50.6,23.7,,,,,5.2,,,,,,,0,bbs,le,,balance,balance,lohse,1,1,26,23.7,18.6,,26,41.1,14.3,,,26,44.9,11.9,0.5,17.4,16.58990657,21.2,15.61361585,1.0488305,1.357789265,0.96969697,1.017047757,Term G OK,All OK,1.316644136,0.059616258,0.073915225,0.056057896,17.83870019,0.069503389,,
1/12/2012,106,michielsen,2011,michielsen (2011),ctrl,233,homebased upper extermity therapy,http://www.ncbi.nlm.nih.gov/pubmed/21051765,Netherlands,Europe,rotterdam,rotterdam,Netherlands,rotterdam,51.9244,4.4777,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/21051765"" target=""_blank"">michielsen (2011)</a>",36,36,Time 50 OK,36,1,42,180,58.7,50th Percentile,,1642.5,>1year,4.5,1,,,,,4,,,,,,,,,,,,,,,,,,1,fma-ue,ue,fma,,fma,lohse,1,1,20,36.4,14.7,,20,36.6,14.2,,,20,36.3,16.2,0.5,0.2,14.45216247,-0.1,15.46819317,0.013838759,-0.006464879,0.96,0.013285209,Term G OK,All OK,-0.006206284,0.050004788,0.050001045,0.046084412,21.69931126,0.046080963,,"the authors state an intention to treat principle, but this is not clear from the flowchart and tables. No sample size is reported in the tables for the different timepoints, so it is assumed that all observations were in fact, carried forward."
1/12/2012,121,outermans,2010,outermans (2010),exp,270,time matched high intensity physiotherapy,http://www.ncbi.nlm.nih.gov/pubmed/20719820,Netherlands,Europe,utrecht,utrecht,Netherlands,utrecht,52.0907,5.1214,"<a href=""http://www.bmj.com/content/344/bmj.e2672"" target=""_blank"">van de port (2012)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/20719820"" target=""_blank"">outermans (2010)</a>",9,9,Time 50 OK,9,1,28,,56.8,25th Percentile,8.6,22.5,<90days,0.061643836,0,,,,,,,,,,,53,,,,,,,,,,,,6,10mwt,le,,speed,speed,lohse,0,1,22,1.5,0.5,,22,1.7,0.5,,,,,,0.5,0.2,0.5,,0.5,0.4,,0.963855422,0.385542169,Term G OK,All OK,,0.049090909,,0.045606303,21.92679376,,,
1/12/2012,113,mudge,2009,mudge (2009),exp,250,circuit training,http://www.ncbi.nlm.nih.gov/pubmed/19969159,New zealand,Australia,auckland,auckland,New zealand,auckland,-36.8485,174.7633,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/19969159"" target=""_blank"">mudge (2009)</a>",12,12,Time 50 OK,12,1,28,90,76,Remaining,,1215.45,>1year,3.33,0,,,,,,,,,,,,,,,,,,,,,,,1,10mwt SSV,le,,speed,speed,lohse,0,1,31,0.76,0.3,,31,0.79,0.28,,,31,0.77,0.26,0.5,0.03,0.290172363,0.01,0.280713377,0.103386828,0.035623525,0.974789916,0.100780437,Term G OK,All OK,0.034725453,0.032430465,0.032278533,0.030815927,32.45075185,0.030671558,,
1/12/2012,118,olawale,2011,olawale (2011),ctrl,262,conventional physiotherapy,http://www.ncbi.nlm.nih.gov/pubmed/21427155,Nigeria,Africa,lagos,lagos,Nigeria,lagos,6.5244,3.3792,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/21427155"" target=""_blank"">olawale (2011)</a>",36,36,Time 50 OK,36,1,84,,57.2,50th Percentile,5.9,309,<1year,0.846575342,0,,,,,,,,,,,,,,,,,,,,,,,3,10mwt SSV,le,,speed,speed,lohse,1,0,20,26.39,11.9,,20,24.65,10.49,,,,,,0.5,-1.74,11.21717656,,11.9,0.155119249,,0.96,0.148914479,Term G OK,All OK,,0.05060155,,0.046634388,21.44340352,,,sign reversed for time measure
1/12/2012,14,brunner,2012,brunner (2012),exp,28,bimanual therapy,http://www.ncbi.nlm.nih.gov/pubmed/22561098,Norway,Europe,bergen,bergen,Norway,bergen,60.3913,5.3221,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/22561098"" target=""_blank"">brunner (2012)</a>",26,26,Time 50 OK,26,1,28,118,64.8,75th Percentile,,36.9,<90days,0.10109589,1,,>24,,,,,,,,,,,,,,,,,,,,,1,arat,ue,arat,,arat,lohse,1,0,16,30.07,13.99,,15,45.27,13.8,,,15,45.53,14.49,0.5,15.2,13.89860015,15.46,14.23357238,1.093635318,1.086164428,0.949152542,1.038026743,Term G OK,All OK,1.030935728,0.099876194,0.099367286,0.089977519,11.11388724,0.089519049,,
1/12/2012,6,bale,2008,bale (2008),ctrl,12,training as usual,http://www.ncbi.nlm.nih.gov/pubmed/18955423,Norway,Europe,Førde,Førde,Norway,Førde,61.4536,5.8497,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/18955423"" target=""_blank"">bale (2008)</a>",16.67,16.67,Time 50 OK,16.67,1,28,,64.9,75th Percentile,,32,<90days,0.087671233,1,,,,,,,,,,,,,,,,,,,,,,,0,gait speed SSV,le,,speed,speed,lohse,0,1,10,0.38,0.3,,10,0.46,0.3,,,,,,0.5,0.08,0.3,,0.3,0.266666667,,0.914285714,0.243809524,Term G OK,All OK,,0.103555556,,0.086563991,11.55214759,,,
1/12/2012,88,langhammer,2010,langhammer (2010),exp,194,outdoor walking,http://www.ncbi.nlm.nih.gov/pubmed/20026572,Norway,Europe,oslo,oslo,Norway,oslo,59.9139,10.7522,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/20026572"" target=""_blank"">langhammer (2010)</a>",41.5,41.5,Time 50 OK,41.5,3,16.9,,75,Remaining,10.4,349,<1year,0.956164384,0,,,,,,,,,,,,,,5.3,,,,,,,,,2,6minwt,le,,capacity,capacity,lohse,0,1,18,299.4,159.3,,18,310.1,164.4,,,,,,0.5,10.7,161.8700868,,159.3,0.066102392,,0.955223881,0.063142584,Term G OK,All OK,,0.055676931,,0.050802564,19.68404587,,Yes,
1/12/2012,25,dahl,2008,dahl (2008),exp,54,CIMT,http://cre.sagepub.com/content/22/5/436.short,Norway,Europe,trondheim,trondheim,Norway,trondheim,63.4305,10.3951,"<a href=""http://cre.sagepub.com/content/22/5/436.short"" target=""_blank"">dahl (2008)</a>",204,132,Time 50 OK,60,1,14,180,62,50th Percentile,,630,>1year,1.726027397,1,,,,,,,,,,,,,,,,,,,,,,,0,wmft,ue,wmft,,wmft,lohse,1,1,18,2.17,0.78,,18,1.56,0.57,0,0,18,1.82,0.8,0.5,-0.61,0.683117852,-0.35,0.790063289,0.892964513,0.443002485,0.955223881,0.852981027,Term G OK,All OK,0.423166553,0.077705156,0.061006978,0.070902277,14.1039194,0.055665979,Yes,sign reversed for time measure
1/12/2012,33,dias,2007,dias (2007),exp,70,bodyweight supported treadmill training,http://www.ncbi.nlm.nih.gov/pubmed/18084173,Portugal,Europe,lisbon,lisbon,Portugal,lisbon,38.7223,-9.1393,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/18084173"" target=""_blank"">dias (2007)</a>",16.67,16.67,Time 50 OK,16.67,1,35,90,70.35,Remaining,7.36,1413,>1year,3.871232877,0,,>19,,,,,,,,51.5,36.85,,,,,10.55,,,,,,,0,motricity index - le,le,,,other,lohse,1,0,20,51.5,14.02,1,20,54.63,,1,0,20,59.95,,0.5,3.13,14.02,8.45,14.02,0.223252496,0.602710414,0.96,0.214322397,Term G OK,All OK,0.578601997,0.051246042,0.059081496,0.047228352,21.17372209,0.054449507,Yes,Difference scores are divided by the standard deviation at baseline
1/12/2012,159,shin,2010,shin (2010),exp,361,game-based therapy using PS2 eyetoy,http://www.koreascience.or.kr/article/ArticleFullRecord.jsp?cn=SHGSCZ_2010_v11n1_368,South korea,Asia,asan,asan,South korea,asan,36.7898,127.0018,"<a href=""http://www.koreascience.or.kr/article/ArticleFullRecord.jsp?cn=SHGSCZ_2010_v11n1_368"" target=""_blank"">shin (2010)</a>",18,18,Time 50 OK,18,1,42,,60.75,50th Percentile,7.53,2075.7,>1year,5.686849315,1,,25.06,,,,,,,,,,,,,,,,,,,,,0,10mwt,le,,speed,speed,lohse,0,0,16,0.86,0.32,,16,1.1,0.34,,,,,,0.5,0.24,0.33015148,,0.32,0.726939039,,0.949152542,0.689976037,Term G OK,All OK,,0.079013761,,0.071182751,14.04834719,,,
1/12/2012,129,park,2013,park (2013),exp,289,overground gait training (less impaired group),https://www.jstage.jst.go.jp/article/jpts/25/4/25_2012-353/_pdf,South korea,Asia,daejeon,daejeon,South korea,daejeon,36.3504,127.3845,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/21245205"" target=""_blank"">park (2011)</a><br><a href=""https://www.jstage.jst.go.jp/article/jpts/25/4/25_2012-353/_pdf"" target=""_blank"">park (2013)</a>",20,20,Time 50 OK,20,1,28,,55.4,25th Percentile,7.2,441,>1year,1.208219178,1,,>23,,,,,4.8,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,0,0,10,298.7,66.6,,10,329.7,68.1,,,,,,0.5,31,67.35417582,,66.6,0.460253572,,0.914285714,0.420803266,Term G OK,All OK,,0.110591668,,0.092445606,10.81717178,,,
1/12/2012,82,kim,2012,kim (2012),ctrl,180,no treatment?,https://www.jstage.jst.go.jp/article/jpts/24/9/24_901/_pdf,South korea,Asia,seoul,seoul,South korea,seoul,37.5665,126.978,"<a href=""http://cre.sagepub.com/content/22/10-11/966.full.pdf"" target=""_blank"">noh (2008)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/19692788"" target=""_blank"">kim (2009)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/22469877"" target=""_blank"">lee (2012)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/23232161"" target=""_blank"">kwon (2012)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/23598900"" target=""_blank"">cho (2013)</a><br><a href=""https://www.jstage.jst.go.jp/article/jpts/24/11/24_1133/_pdf"" target=""_blank"">jung (2012)</a><br><a href=""https://www.jstage.jst.go.jp/article/jpts/24/11/24_1205/_article"" target=""_blank"">kihoon (2012)</a><br><a href=""https://www.jstage.jst.go.jp/article/jpts/24/9/24_901/_pdf"" target=""_blank"">kim (2012)</a>",0,0,Time 50 OK,0,1,21,,55,25th Percentile,,385,>1year,1.054794521,0,,25.14,,,,,,,,,,,,,,,,,,,,,3,fim,,,,other,lohse,0,0,7,101,7.89,,7,101.28,8.11,,,7,,,0.5,0.28,8.000756214,,7.89,0.034996692,,0.869565217,0.030431906,Term G OK,All OK,,0.142944626,,0.108086674,9.25183432,,,
1/12/2012,28,de deigo,2013,de deigo (2013),exp,60,sensory stimulation + functional activity training,http://www.ncbi.nlm.nih.gov/pubmed/23524843,Spain,Europe,barcelona,barcelona,Spain,barcelona,41.3851,-2.1734,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/23524843"" target=""_blank"">de deigo (2013)</a>",44,44,Time 50 OK,44,1,56,,61.9,50th Percentile,,1341,>1year,3.673972603,0,,,,,,,,,,,,,,,,,,,,,,,0,fma,ue,fma,,fma,lohse,0,0,12,24.3,4.6,,12,29.4,4.9,0,,,,,0.5,5.1,4.752367831,,4.6,1.073149256,,0.930232558,0.998278377,Term G OK,All OK,,0.131318722,,0.113634373,8.800154158,,Yes,
1/12/2012,116,nilsson,2001,nilsson (2001),ctrl,258,overground walking training,http://www.ncbi.nlm.nih.gov/pubmed/11594641,Sweden,Europe,gothenburg,gothenburg,Sweden,gothenburg,57.7089,11.9746,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/11594641"" target=""_blank"">nilsson (2001)</a>",47.14,47.14,Time 50 OK,47.14,1,66,280,56,25th Percentile,12.1,17,<90days,0.046575342,1,8,,,,,,0,,,,23.3,,,,,,,,,,,,1,fim,,,,other,lohse,0,0,37,56.1,18,1,36,76.9,,1,0,32,81.9,,0.5,20.8,18,25.8,18,1.155555556,1.433333333,0.979020979,1.131313131,Term G OK,All OK,1.403263403,0.045071738,0.05478979,0.043200453,23.14790542,0.052515032,,
1/12/2012,150,rydwik,2006,rydwik (2006),ctrl,341,no therapy,http://www.ncbi.nlm.nih.gov/pubmed/16944822,Sweden,Europe,järfälla,järfälla,Sweden,järfälla,59.4349,17.8071,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/16944822"" target=""_blank"">rydwik (2006)</a>",0,0,Time 50 OK,0,1,42,84,75.3,Remaining,4.9,1647,>1year,4.512328767,1,,,,,,,,,,,,,,,,,,,,,,,0,TUG,le,,,other,lohse,0,0,9,47,45,,9,44,40,,,9,,,0.5,-3,42.57346591,,45,0.070466426,,0.903225806,0.063647095,Term G OK,All OK,,0.111386973,,0.09087137,11.00456612,,Yes,sign reversed for time measure
1/12/2012,52,globas,2012,globas (2012),exp,111,high intensity treadmill training,http://www.ncbi.nlm.nih.gov/pubmed/21885867,Switzerland,Europe,zurich,zurich,Switzerland,zurich,47.3769,8.5417,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/21885867"" target=""_blank"">globas (2012)</a>",19.5,19.5,Time 50 OK,19.5,2,90,365,68.6,Remaining,6.7,1800,>1year,4.931506849,1,4.2,,,,,,,,91.7,,,,,,,13.2,,,,,,,2,6minwt,le,,capacity,capacity,lohse,0,1,18,274.4,113,,18,332.1,138,,,18,305.9,158,0.5,57.7,126.1209737,31.5,137.3553785,0.457497261,0.229332119,0.955223881,0.437012309,Term G OK,All OK,0.219063517,0.061369548,0.057016478,0.055996808,17.85816077,0.052024837,Yes,
1/12/2012,208,yang,2014,yang (2014),ctrl,474,conventional rehabilitation up to the cross-over point,http://www.ncbi.nlm.nih.gov/pubmed/24388057,Taiwan,Asia,kaohsiung,kaohsiung,Taiwan,kaohsiung,22.6273,120.3014,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/24388057"" target=""_blank"">yang (2014)</a>",20,20,Time 50 OK,20,1,28,,54.5,25th Percentile,,333,<1year,0.912328767,1,,,,,4.2,,,16.5,,,,,,,,,,1.2,,,,,0,fma-le,le,,,other,lohse,0,0,15,20.5,10.2,,15,20.7,10,,,15,,,0.5,0.2,10.10049504,,10.2,0.01980101,,0.945454545,0.018720955,Term G OK,All OK,,0.066679736,,0.059603969,16.77740622,,,Data taken up to the crossover point
1/12/2012,63,hsieh,2012,hsieh (2012),exp,137,high dose robot assisted therapy,http://www.ncbi.nlm.nih.gov/pubmed/22895994,Taiwan,Asia,taipei,taipei,Taiwan,taipei,25.033,121.5654,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/15759530"" target=""_blank"">wang (2005)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/15859527"" target=""_blank"">yang (2005)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/17008338"" target=""_blank"">yang (2006)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/17321816"" target=""_blank"">wuB (2007)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/17507641"" target=""_blank"">yen (2008)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/17678656"" target=""_blank"">wu (2007)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/18358724"" target=""_blank"">yang (2008)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/20382280"" target=""_blank"">yang (2010)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/20947493"" target=""_blank"">wu (2010)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/21436390"" target=""_blank"">hsieh (2011)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/22228607"" target=""_blank"">wu (2012)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/22895994"" target=""_blank"">hsieh (2012)</a>",30,30,Time 50 OK,30,4,28,,56.5,25th Percentile,,860,>1year,2.356164384,1,,28.5,,,,,,,,,,,,,,,,<3,,,,,0,fma-ue,ue,fma,,fma,lohse,1,1,18,42.8,8.86,,18,48,8.2,,,,,,0.5,5.2,8.536380966,,8.86,0.609157443,,0.955223881,0.581881736,Term G OK,All OK,,0.065863133,,0.060096991,16.6397682,,Yes,
1/12/2012,96,lin,2010,lin (2010),ctrl,211,standard OT,http://www.ncbi.nlm.nih.gov/pubmed/19729583,Taiwan,Asia,taoyuan,taoyuan,Taiwan,taoyuan,24.9936,121.301,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/18042603"" target=""_blank"">lin (2007)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/19729583"" target=""_blank"">lin (2010)</a>",30,30,Time 50 OK,30,1,21,,55.5,25th Percentile,,393.6,>1year,1.078356164,0,,>24,,,5,,,,,,,,,<2,,,,,,,,,0,fma,ue,fma,,fma,lohse,0,0,17,53.53,7.58,,17,54.99,1,,,,,,0.5,1.46,5.406311127,,7.58,0.27005475,,0.952380952,0.257195,Term G OK,All OK,,0.060968517,,0.055300242,18.08310351,,,
1/12/2012,169,sungkarat,2011,sungkarat (2011),ctrl,386,conventional programme of gait retraining,http://www.ncbi.nlm.nih.gov/pubmed/21148267,Thailand,Asia,chiang mai,chiang mai,Thailand,chiang mai,18.7061,98.9817,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/21148267"" target=""_blank"">sungkarat (2011)</a>",15,15,Time 50 OK,15,1,21,,53.83,25th Percentile,11.18,141,<1year,0.38630137,0,,,,,,,,,,,,,,,,,,,,,,3.44,2,gait speed,le,,speed,speed,lohse,1,0,18,22.24,9.1,,18,26.3,8.5,,,,,,0.5,4.06,8.805112151,,9.1,0.461095774,,0.955223881,0.440449694,Term G OK,All OK,,0.06146137,,0.05608059,17.83148144,,,
1/12/2012,72,johannsen,2010,johannsen (2010),exp,158,bilateral arm training with auditory cuing,http://www.ncbi.nlm.nih.gov/pubmed/19822721,UK,Europe,birmingham,birmingham,UK,birmingham,52.4862,-1.8904,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/19822721"" target=""_blank"">johannsen (2010)</a>",7.5,7.5,Time 50 OK,7.5,1,42,90,68.1,Remaining,10.19,2253,>1year,6.17260274,1,,,,,,,,,,,,,,,,,,,,,,,2,fma ue,ue,fma,,fma,lohse,1,0,10,37.41,21.72,1,10,42.41,,1,0,10,38.51,,0.5,5,21.72,1.1,21.72,0.230202578,0.050644567,0.914285714,0.210470929,Term G OK,All OK,0.046303604,0.102649661,0.100128244,0.085806737,11.65409658,0.083699038,,change means and standard deviations calculated from figures
1/12/2012,132,partridge,2000,partridge (2000),exp,298,CPT + CPT,http://www.ncbi.nlm.nih.gov/pubmed/11129665,UK,Europe,canterbury,canterbury,UK,canterbury,51.2802,-1.0789,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/11129665"" target=""_blank"">partridge (2000)</a>",30,30,Time 50 OK,30,1,42,180,,Not Available,,0,NA,,0,,,,,,,,,,,,,,,,,,,,,,,2,profiles of recovery,,,,other,lohse,1,0,54,4.6,4.1,,52,9.5,4.2,,,44,9,4.2,0.5,4.9,4.149339614,4.4,4.145089967,1.180910809,1.061496864,0.985781991,1.164120608,Term G OK,All OK,1.046404491,0.031431022,0.028951626,0.030543602,32.74008089,0.028134209,,
1/12/2012,112,morris,2008,morris (2008),exp,248,bilateral task specific training,http://www.ncbi.nlm.nih.gov/pubmed/18586126,UK,Europe,dundee,dundee,UK,dundee,56.462,2.9707,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/18586126"" target=""_blank"">morris (2008)</a>",10,10,Time 50 OK,10,4,42,126,67.9,Remaining,,22.6,<90days,0.061917808,1,,,,,,,,,58.5,,,,,2,,3.4,,,,,,,5,arat,ue,arat,,arat,lohse,1,0,56,13.4,15.3,,51,27.9,19.5,,,46,29,21.9,0.5,14.5,17.42670365,15.6,18.56270454,0.832056383,0.84039478,0.98630137,0.82065835,Term G OK,All OK,0.828882523,0.024038552,0.024163066,0.023384472,42.7634201,0.023505598,,
1/12/2012,48,GAPS Group,2004,GAPS Group (2004),exp,104,CPT + CPT,http://www.ncbi.nlm.nih.gov/pubmed/15293487,UK,Europe,glasgow,glasgow,UK,glasgow,55.8642,-4.2518,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/15293487"" target=""_blank"">GAPS Group (2004)</a>",23.33333333,23.33333333,Time 50 OK,23.33333333,1,28,180,68,Remaining,,35,<90days,0.095890411,1,,,,,,,,11.8,,110,,,,,,5.2,,,0.685714286,,,,1,motricity,,,,other,lohse,0,1,35,110,43,,34,119,46,,,32,124,42,0.5,9,44.50289275,14,42.52601014,0.202234045,0.329210287,0.977777778,0.197739955,Term G OK,All OK,0.321894503,0.029155694,0.030119706,0.027874284,35.87536096,0.028795926,Yes,
1/12/2012,23,crosbie,2012,crosbie (2012),ctrl,51,standard therapy matched to the control group,http://www.ncbi.nlm.nih.gov/pubmed/22275463,UK,Europe,newtonabbey,newtonabbey,UK,newtonabbey,54.6792,-5.9591,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/22275463"" target=""_blank"">crosbie (2012)</a>",6.75,6.75,Time 50 OK,6.75,1,21,201,64.6,75th Percentile,,300,<1year,0.092767123,0,,,,,,,,,,,,,,,,,,,,,,,0,motricity index-ue,ue,,,other,lohse,0,1,9,77.4,19.5,,8,85,22.1,,,8,81.6,20.9,0.5,7.6,20.75390726,4.2,20.16543247,0.366196105,0.208277209,0.903225806,0.330757772,Term G OK,All OK,0.18812135,0.118561088,0.113521078,0.096724134,10.33868135,0.092612409,,
1/12/2012,22,cooke,2010,cooke (2010),exp,49,CPT+FST,http://www.ncbi.nlm.nih.gov/pubmed/19704158,UK,Europe,norfolk,norwich,UK,norwich,52.6309,-1.2974,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/19109444"" target=""_blank"">donaldson (2009)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/19704158"" target=""_blank"">cooke (2010)</a>",23.5,23.5,Time 50 OK,23.5,1,42,84,71.2,Remaining,,33.86,<90days,0.092767123,1,,,,,,,,,,>28,,,,,,30.3,,,,,,,0,10mwt,le,,speed,speed,lohse,1,1,36,0.23,0.29,,36,0.42,0.39,0,0,29,0.46,0.37,0.5,0.19,0.343656806,0.23,0.327973576,0.552877164,0.701276007,0.978417266,0.540944563,Term G OK,All OK,0.686140554,0.032023238,0.034608167,0.030655857,32.62019392,0.03313041,Yes,
1/12/2012,151,sackley,1997,sackley (1997),ctrl,343,balance training without visual feedback,http://www.ncbi.nlm.nih.gov/pubmed/9442992,UK,Europe,nottingham,nottingham,UK,nottingham,52.9548,-1.1581,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/9442992"" target=""_blank"">sackley (1997)</a>",12,12,Time 50 OK,12,1,28,84,67.9,Remaining,,131.8,<1year,0.36109589,0,,,,,,,,,,,,,,,,10.2,,,,,,,1,rivermead motor assessment,,,,other,lohse,0,0,13,10.2,4.1,,12,12.7,4.5,,,12,15.5,4.7,0.5,2.5,4.295953607,5.3,4.397182893,0.58194297,1.205317161,0.936170213,0.544797674,Term G OK,All OK,1.128382023,0.08994837,0.132799595,0.078832071,12.68519255,0.116387512,,
1/12/2012,187,wade,1992,wade (1992),ctrl,424,delayed physiotherapy,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1881332/,UK,Europe,oxford,oxford,UK,oxford,51.752,-1.2577,"<a href=""http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1881332/"" target=""_blank"">wade (1992)</a>",0,0,Time 50 OK,0,1,,,72,Remaining,,1788,>1year,4.898630137,0,,,,,,,4,,,,,,,,,,,,,,,,4,10mwt,le,,speed,speed,lohse,0,0,43,44.3,37.2,,39,47.9,38.6,,,,,,0.5,3.6,37.87145363,,37.2,-0.095058406,,0.982035928,-0.09335077,Term G OK,All OK,,0.023360885,,0.02252911,44.38701751,,,sign reversed for time measure; data only taken up to the 28 week assessment
1/12/2012,192,werner,1996,werner (1996),ctrl,438,no outpatient therapy,http://www.ncbi.nlm.nih.gov/pubmed/8630191,USA,North America,MI,ann arbor,USA,ann arbor,42.2808,-83.743,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/8630191"" target=""_blank"">werner (1996)</a>",0,0,Time 50 OK,0,1,84,270,66,75th Percentile,,1204.5,>1year,3.3,0,,,,70,,,,,,,,,,,,,,,,13,,,0,fim,,,,other,lohse,0,0,16,70,19,1,16,71.5,,0,1,16,70.5,,0.5,1.5,19,0.5,19,0.078947368,0.026315789,0.949152542,0.074933095,Term G OK,All OK,0.024977698,0.062694771,0.062521641,0.056481127,17.70502915,0.056325156,,
1/12/2012,199,wolf,2006,wolf (2006),ctrl,453,standard care,http://www.ncbi.nlm.nih.gov/pubmed/17077374,USA,North America,GA,atlanta,USA,atlanta,33.749,-84.388,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/17077374"" target=""_blank"">wolf (2006)</a>",0,0,Time 50 OK,0,1,14,365,63.3,75th Percentile,,187.7,<1year,0.514246575,1,,27.5,,,,,,,,,,,,,52.2,,,0.92,,,,,11,wmft-time,ue,wmft,,wmft,lohse,1,1,115,3.18,1.37,,104,3.1,1.37,,,86,2.87,1.37,0.5,-0.08,1.37,-0.31,1.37,0.058394161,0.226277372,0.993406593,0.058009144,Term G OK,All OK,0.224785434,0.008710478,0.008918267,0.008595993,116.333273,0.008801051,Yes,"Outcome measure is WMFT-time, so lower numbers mean better performance; Authors report ITT analysis, but different numbers are reported for the different timepoints in the tables"
1/12/2012,21,conroy,2011,conroy (2011),exp,46,robot assisted therapy with gravity compensation,http://www.ncbi.nlm.nih.gov/pubmed/21849168,USA,North America,MD,baltimore,USA,baltimore,39.2904,-76.6122,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/16151035"" target=""_blank"">macko (2005)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/20930212"" target=""_blank"">whitall (2011)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/21849168"" target=""_blank"">conroy (2011)</a>",18,18,Time 50 OK,18,1,42,126,60,50th Percentile,,1825,>1year,5,1,,,,,,,,,,,,,,,70.6,,,,,,,,5,fma-ue,ue,fma,,fma,lohse,1,0,21,16.5,10.6,1,16,18.2,,1,0,16,19.11,,0.5,1.7,10.6,2.61,10.6,0.160377358,0.246226415,0.962025316,0.154287079,Term G OK,All OK,0.236876045,0.04823145,0.049062558,0.044637855,22.40251016,0.04540704,,
1/12/2012,198,wittenberg,2003,wittenberg (2003),exp,450,modified CIMT,http://www.ncbi.nlm.nih.gov/pubmed/12645445,USA,North America,MD,bethesda,USA,bethesda,38.9847,-77.0947,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/12645445"" target=""_blank"">wittenberg (2003)</a>",216,136,Time 50 OK,56,1,10,,65,75th Percentile,,1020,>1year,2.794520548,1,,,,,,,,,,,,,,,,,,,,,,,0,wmft,ue,wmft,,wmft,lohse,0,0,9,6.7,2,1,9,7.55,,,,,,,0.5,0.85,2,,2,0.425,,0.903225806,0.383870968,Term G OK,All OK,,0.121145833,,0.098832813,10.11809711,,,
1/12/2012,172,taub,2006,taub (2006),exp,393,CIMT,http://stroke.ahajournals.org/content/37/4/1045.abstract,USA,North America,AL,birmingham,USA,birmingham,33.5207,-86.8025,"<a href=""http://stroke.ahajournals.org/content/37/4/1045.abstract"" target=""_blank"">taub (2006)</a>",172,116,Time 50 OK,60,1,14,730,54.6,25th Percentile,,1314,>1year,3.6,0,,,,,,,,,,,,,,,,,,,,,,,0,actual amount of use test,,,,other,lohse,0,0,21,0.8,0.4,,21,1.5,0.9,,,,,,0.5,0.7,0.696419414,,0.4,1.005141422,,0.962025316,0.966971495,Term G OK,All OK,,0.07167403,,0.066333793,15.07527242,,Yes,
1/12/2012,163,stein,2004,stein (2004),exp,370,robot aided progressive resistence training,http://www.ncbi.nlm.nih.gov/pubmed/15314537,USA,North America,MA,boston,USA,boston,42.3601,-71.0589,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/15314537"" target=""_blank"">stein (2004)</a>",18,18,Time 50 OK,18,1,42,,53.3,25th Percentile,,810,>1year,2.219178082,0,,,,,,,,,,,,,,,,,,10.3,,,,,1,fma-ue,ue,fma,,fma,lohse,1,0,9,38,9.6,1,9,43.2,,,,,,,0.5,5.2,9.6,,9.6,0.541666667,,0.903225806,0.489247312,Term G OK,All OK,,0.127411265,,0.103944258,9.62054104,,,
1/12/2012,61,housman,2009,housman (2009),ctrl,131,conventional physical and occupational therapy,http://www.ncbi.nlm.nih.gov/pubmed/19237734,USA,North America,IL,chicago,USA,chicago,41.8781,-87.6298,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/18467648"" target=""_blank"">hornby (2008)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/19237734"" target=""_blank"">housman (2009)</a>",24,24,Time 50 OK,24,2,63,243,56.4,25th Percentile,,3372,>1year,9.238356164,0,,,,,,,,,,,,,,,,,,,,,,,1,fma-ue,ue,fma,,fma,lohse,1,0,14,18.1,5,1,14,20.3,,1,0,14,19.6,,0.5,2.2,5,1.5,5,0.44,0.3,0.941176471,0.414117647,Term G OK,All OK,0.282352941,0.078342857,0.074642857,0.069397133,14.40981719,0.066119624,,
1/12/2012,124,page,2008,page (2008),exp,278,mCIMT,http://www.ncbi.nlm.nih.gov/pubmed/18174447,USA,North America,OH,cincinnati,USA,cincinnati,39.1031,-84.512,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/14970962"" target=""_blank"">page (2004)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/15673841"" target=""_blank"">page (2005)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/18174447"" target=""_blank"">page (2008)</a>",265,135,Time 50 OK,15,1,70,,57.9,50th Percentile,8.4,1194,>1year,3.271232877,0,,,>69,,,,,,,,,,,,,,,<3,,,,,0,arat,ue,arat,,arat,lohse,1,0,13,27.71,7.41,,13,40.54,8.18,,,,,,0.5,12.83,7.804501906,,7.41,1.643922976,,0.936170213,1.538991722,Term G OK,All OK,,0.180864721,,0.158512494,6.308650976,,Yes,
1/12/2012,40,duncan,2011,duncan (2011),ctrl,87,late locomotor (pre-crossover),http://www.nejm.org/doi/full/10.1056/NEJMoa1010790,USA,North America,NC,durham,USA,durham,35.994,-78.8986,"<a href=""http://www.nejm.org/doi/full/10.1056/NEJMoa1010790"" target=""_blank"">duncan (2011)</a>",22.5,22.5,Time 50 OK,22.5,3,98,98,63.3,75th Percentile,12.5,64.18,<90days,0.175835616,1,,26.2,,,,,,,,,,,,,55.7,,,,3.08,,,,,gait speed comfortable,le,,speed,speed,lohse,1,1,143,0.38,0.23,1,143,0.51,,1,0,143,,,0.5,0.13,0.23,,0.23,0.565217391,,0.994708995,0.562226823,Term G OK,All OK,,0.008110037,,0.008024444,124.619226,,Yes,
1/12/2012,188,waldman,2013,waldman (2013),ctrl,426,instructed home exercise program,http://www.ncbi.nlm.nih.gov/pubmed/23648617,USA,North America,IL,evanston,USA,evanston,42.0451,-87.6877,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/23648617"" target=""_blank"">waldman (2013)</a>",9,9,Time 50 OK,9,3,42,84,53,25th Percentile,7.1,894,>1year,2.449315068,0,,,,,,,,,,,,,,,,,,,,,,,0,STREAM,,,,other,lohse,0,0,12,30.3,7.7,,12,31.7,8,,,12,32.5,8.3,0.5,1.4,7.85143299,2.2,8.005623024,0.178311399,0.274806844,0.930232558,0.165871069,Term G OK,All OK,0.255634274,0.084658123,0.08647995,0.073257435,13.65049158,0.074833921,,
1/12/2012,17,cauraugh,2003,cauraugh (2003),ctrl,35,bilateral arm training,http://www.ncbi.nlm.nih.gov/pubmed/14568122,USA,North America,FL,gainesville,USA,gainesville,29.6516,-82.3248,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/12920254"" target=""_blank"">duncan (2003)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/14568122"" target=""_blank"">cauraugh (2003)</a>",6,6,Time 50 OK,6,1,14,,66.4,75th Percentile,,1022,>1year,2.8,0,,,,,,,,,,,,,,,,,,,,,,,0,box and block test,ue,,,other,lohse,0,0,6,15.1,7.8,,6,14.5,11.3,,,,,,0.5,-0.6,9.709016428,,7.8,-0.061798227,,0.842105263,-0.052040612,Term G OK,All OK,,0.166984918,,0.118415898,8.44481203,,,
1/12/2012,44,fisher,2011,fisher (2011),exp,95,robot assited gait therapy,http://www.ncbi.nlm.nih.gov/pubmed/21642064,USA,North America,TX,houston,USA,houston,29.7604,-95.3698,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/17172550"" target=""_blank"">boake (2007)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/21642064"" target=""_blank"">fisher (2011)</a>",24,24,Time 50 OK,24,2,56,,60,50th Percentile,14,57,<90days,0.156164384,0,,,,,,,,,,,,,,,,,,,,,,,0,walk time (8 meters),le,,,other,lohse,0,0,10,143,105,,10,56,73,,,,,,0.5,-87,90.42676595,,105,0.962104517,,0.914285714,0.879638416,Term G OK,All OK,,0.146282255,,0.122280024,8.177950636,,Yes,sign reversed for time measure
1/12/2012,156,schmid,2012,schmid (2012),ctrl,353,waitlisted control group,http://www.ncbi.nlm.nih.gov/pubmed/22836351,USA,North America,IN,indianapolis,USA,indianapolis,39.7684,-86.1581,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/22836351"" target=""_blank"">schmid (2012)</a>",0,0,Time 50 OK,0,1,56,,60.2,50th Percentile,,1092,>1year,2.991780822,1,,,,,,,,,,,,,,,,,,,,,,,1,bbs,le,,balance,balance,lohse,0,1,10,41.9,6.4,,10,43.8,6.3,,,,,,0.5,1.9,6.350196847,,6.4,0.299203323,,0.914285714,0.273557324,Term G OK,All OK,,0.104476131,,0.087333517,11.4503576,,,
1/12/2012,76,kahn,2006,kahn (2006),ctrl,166,dosage matched unassisted reaching,http://www.jneuroengrehab.com/content/3/1/12,USA,North America,CA,irvine,USA,irvine,33.6839,-117.7947,"<a href=""http://www.jneuroengrehab.com/content/3/1/12"" target=""_blank"">kahn (2006)</a>",18,18,Time 50 OK,18,4,56,180,55.9,25th Percentile,,3093,>1year,8.473972603,0,,,,,,,,,,,,,,,,,,,,,,,0,chedoke mcmaster,,,,other,lohse,0,0,9,3.2,1,1,9,3.5,,,,8,,,0.5,0.3,1,,1,0.3,,0.903225806,0.270967742,Term G OK,All OK,,0.116111111,,0.094725402,10.55683036,,,
1/12/2012,167,sullivan,2007,sullivan (2007),exp,379,cycling with upper extremity ergomety,http://www.ncbi.nlm.nih.gov/pubmed/17895349,USA,North America,CA,los angeles,USA,los angeles,34.0522,-118.2437,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/11994808"" target=""_blank"">sullivan (2002)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/15083439"" target=""_blank"">winstein (2004)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/17895349"" target=""_blank"">sullivan (2007)</a>",24,24,Time 50 OK,24,1,42,222,63.4,75th Percentile,8.6,852,>1year,2.334246575,1,,,,,,,,,,,42.6,,,,,,,,,,,,2,10mwt SSV,le,,speed,speed,lohse,1,1,20,0.43,0.25,,18,0.44,0.28,,,14,0.43,0.26,0.5,0.01,0.264590879,0,0.254109966,0.037794198,0,0.96,0.03628243,Term G OK,All OK,0,0.05003571,0.05,0.04611291,21.68590098,0.04608,,
1/12/2012,144,rabadi,2008,rabadi (2008),exp,328,robot assisted therapy,http://www.ncbi.nlm.nih.gov/pubmed/19052246,USA,North America,OK,oklahoma city,USA,oklahoma city,35.0078,-97.0929,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/19052246"" target=""_blank"">rabadi (2008)</a>",85.85,85.85,Time 50 OK,85.85,1,36.32,,79.5,Remaining,6.17,19,<90days,0.052054795,1,,16.56,,34.6,,,,,,5.9,,,,,,,,1,,,,,0,fma - shoulder elbow scale,ue,fma,,fma,lohse,1,0,10,5.8,3.79,,10,8.03,5.565608682,,,,,,0.5,2.23,4.761307594,,3.79,0.468358735,,0.914285714,0.4282137,Term G OK,All OK,,0.110967995,,0.092760185,10.78048734,,,
1/12/2012,98,lo,2010,lo (2010),exp,217,intensive Robot assisted therapy,http://www.nejm.org/doi/full/10.1056/NEJMoa0911341,USA,North America,RI,providence,USA,providence,41.824,-71.4128,"<a href=""http://www.nejm.org/doi/full/10.1056/NEJMoa0911341"" target=""_blank"">lo (2010)</a>",33,33,Time 50 OK,33,4,84,252,66,75th Percentile,,1314,>1year,3.6,1,,,,,,,,,,,,,,,49.2,,,0.8,,,,,5,fma-ue,ue,fma,,fma,lohse,1,0,49,19.7,10.7,1,47,23.57,,1,0,47,24.5,,0.5,3.87,10.7,4.8,10.7,0.361682243,0.448598131,0.984293194,0.35600137,Term G OK,All OK,0.441552087,0.021743,0.022461636,0.021065338,47.47134843,0.021761576,,
1/12/2012,194,westlake,2009,westlake (2009),exp,442,gait training with lokomat,http://www.ncbi.nlm.nih.gov/pubmed/19523207,USA,North America,CA,san francisco,USA,san francisco,37.7749,-122.4194,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/19523207"" target=""_blank"">westlake (2009)</a>",6,6,Time 50 OK,6,3,28,,58.6,50th Percentile,16.9,1314,>1year,3.6,0,,,,,,,,,,,,,,,,,,,,,,,0,gait speed 4.3m SSV,le,,speed,speed,lohse,1,0,8,0.62,0.31,,8,0.72,0.38,,,,,,0.5,0.1,0.346770818,,0.31,0.2883749,,0.888888889,0.256333245,Term G OK,All OK,,0.130197505,,0.102872103,9.720808371,,,
1/12/2012,36,dromerick,2000,dromerick (2000),ctrl,77,standard care,http://www.ncbi.nlm.nih.gov/pubmed/11108760,USA,North America,MO,st. louis,USA,st. louis,38.627,-90.1994,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/11108760"" target=""_blank"">dromerick (2000)</a>",20,20,Time 50 OK,20,1,14,,71.4,Remaining,,0,NA,0,1,7.5,23.5,,,,,,,,,,,,>3,,,,,,,,,0,arat,ue,arat,,arat,lohse,1,0,9,27.9,20.7,,9,44.3,11.1,,,,,,0.5,16.4,16.60873264,,20.7,0.987432356,,0.903225806,0.891874386,Term G OK,All OK,,0.165279037,,0.134837424,7.416338657,,Yes,
1/12/2012,15,burgar,2011,burgar (2011),ctrl,31,standard care,http://www.ncbi.nlm.nih.gov/pubmed/21674393,USA,North America,TX,temple,USA,temple,31.0982,-97.3428,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/21674393"" target=""_blank"">burgar (2011)</a>",9.4,9.4,Time 50 OK,9.4,1,21,180,68.1,Remaining,,10.6,<90days,0.029041096,1,,>22,,26.9,,,,,,,,,,,,,,0.33,,,,,6,fma,ue,fma,,fma,lohse,1,0,18,24.2,20.3646753,1,18,38.2,,1,0,12,39.5,,0.5,14,20.3646753,15.3,20.3646753,0.687464926,0.751300955,0.955223881,0.656682915,Term G OK,All OK,0.717660614,0.068683556,0.071234809,0.062670494,15.95647228,0.064998391,Yes,
1/12/2012,13,brokaw,2014,brokaw (2014),ctrl,26,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/24297763,USA,North America,DC,washington DC,USA,washington DC,38.9072,-77.0369,"<a href=""http://www.ncbi.nlm.nih.gov/pubmed/19109447"" target=""_blank"">hidler (2009)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/19458319"" target=""_blank"">dromerick (2009)</a><br><a href=""http://www.ncbi.nlm.nih.gov/pubmed/24297763"" target=""_blank"">brokaw (2014)</a>",12,12,Time 50 OK,12,1,30,,57,25th Percentile,,1095,>1year,3,0,,,,,,,,,,,,6.1,,,,,,,,,,,0,fma,ue,fma,,fma,lohse,0,0,5,17.6,4.35,,5,18.39,4.38,,,,,,0.5,0.79,4.365025773,,4.35,0.18098404,,0.8,0.144787232,Term G OK,All OK,,0.203275522,,0.130096334,7.686611677,,,means and SDs estimated from Figure 4
